Palmitic Acid Modulates Microglial Cell Response to Metabolic Endotoxemia in an In Vitro Study

Nutrients. 2023 Aug 5;15(15):3463. doi: 10.3390/nu15153463.

Abstract

Metabolic endotoxemia (ME) is characterized by a 2-3-fold increase in blood endotoxin levels and low-grade systemic inflammation without apparent infection. ME is usually accompanied by metabolic syndrome, characterized by central obesity and hyperlipidemia. According to numerous studies, ME may lead to functional brain disorders, including cognitive decline, depression, and dementia. In the current in vitro study, we aimed to determine the direct and indirect impact of endotoxin (LPS) and palmitic acid (PA), representing saturated fatty acids, on the inflammatory and oxidative stress response in the human microglial HMC3 cells unstimulated and stimulated with IFNγ. The study's results revealed that direct HMC3 cell exposition to endotoxin and PA increased inflammatory response measured as levels of IL-6 and MCP-1 released into the medium and PGE2 levels in cell lysates. Moreover, direct HMC3 cell treatment with PA and LPS induced oxidative stress, i.e., ROS and COX-2 production and lipid peroxidation. On the contrary, an indirect effect of LPS and PA on microglial cells, assessed as the impact of macrophage metabolites, was much lower regarding the inflammatory response, although still associated with oxidative stress. Interestingly, IFNγ had a protective effect on microglial cells, reducing the production of pro-inflammatory mediators and oxidative stress in HMC3 cells treated directly and indirectly with LPS and PA.

Keywords: inflammation; metabolic endotoxemia; microglial cells; oxidative stress; palmitic acid.

MeSH terms

  • Endotoxemia* / metabolism
  • Humans
  • Inflammation / metabolism
  • Lipopolysaccharides / pharmacology
  • Microglia*
  • Palmitic Acid / metabolism
  • Palmitic Acid / pharmacology

Substances

  • Palmitic Acid
  • Lipopolysaccharides

Grants and funding

This research received no external funding.